Skip to main content
. 2019 May 30;13:1753944719851950. doi: 10.1177/1753944719851950

Table 1.

Summary of recent results obtained from preclinical models, healthy populations and those with chronic diseases, such as depression or cardiovascular disease, during female-specific reproductive events.

Reproductive event associated with greater risk for depression and CVD in women Change to inflammatory markers
Pro-inflammatory Anti-inflammatory
Oral contraceptive use ↑ CRP, uric acid
↕ PAI-1
Perinatal depression ↑ IL-1β, IL-6, IL-15, IL-18, IL-23, IL-33, PAI-1, CCL3 ↓ IL-10
Gestational diabetes ↑ IL-6, IL-12, CRP, TNF-α ↓ IL-4, IL-10
Preeclampsia ↑ IL-1β, IL-6, IL-8, CRP, TNF-α, IFN-γ ↑ IL-10
Menopausal transition ↑ sTNFR1, sTNFR2, glycoprotein acetyls, haptoglobin
↓ CRP, IL-1α, IL-3
↕ IL-8

Changes to inflammatory markers vary depending on the population studied, type and timing of sample collection.

CCL3, chemokine ligand 3; CRP, C-reactive protein; CVD, cardiovascular disease; IFN-γ, interferon gamma; IL, interleukin; PAI-1, plasminogen-activator inhibitor 1; sTNFR1, soluble TNF-receptor 1; sTNFR2, soluble TNF-receptor 2; TNF-α, tumor necrosis factor alpha.